Search Within

Sergio Andres Giralt

Formats
  1. Meeting Abstract (642)
  2. Journal Article (376)
  3. Research Letter (20)
  4. Review (15)
  5. Guidelines (5)
  6. Correspondence (4)
  7. Editorial (4)
  8. Book Section (3)
Groups
  1. Bone Marrow Transplant (1069)
  2. Center for Hematologic Malignancies (1069)
  3. Department of Medicine (1069)
  4. Hematologic Malignancies, Division of (1069)
  5. Survivorship Research (703)
  6. CTCR Scholars (557)

More Groups

People
  1. Miguel-Angel Perales (429)
  2. Sean Devlin (380)
  3. Gunjan Shah (311)
  4. Michael Scordo (279)
  5. Heather Landau (263)
  6. Ann Jakubowski (242)

More People

Years
  1. 2025 (18)
  2. 2024 (65)
  3. 2023 (104)
  4. 2022 (77)
  5. 2021 (66)
  6. 2020 (91)

More Years

Publications
  1. Blood (314)
  2. Biology of Blood and Marrow Transplantation (275)
  3. Bone Marrow Transplantation (80)
  4. Clinical Lymphoma, Myeloma and Leukemia (60)
  5. Journal of Clinical Oncology (40)
  6. Transplantation and Cellular Therapy (36)

More Publications

Publishers
  1. Elsevier Inc. (386)
  2. American Society of Hematology (349)
  3. Nature Publishing Group (110)
  4. American Society of Clinical Oncology (42)
  5. Taylor & Francis Group (35)
  6. Ferrata Storti Foundation (13)

More Publishers

Results (1069)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Indications for hematopoietic stem cell transplantation in patients with Waldenstrom's Macroglobulinemia: A consensus project of the EBMT Lymphoma Working Party (LWP)/European Consortium for Waldenstrom's Macroglobulinemia (ECWM)/International Waldenstrom's Macroglobulinemia Foundation (IWMF)
    Meeting Abstract

    Kyriakou, C.; Advani, R. H.; Ansell, S. M.; Buske, C.; Castillo, J. J.; Dreger, P.; Gertz, M. A.; Giralt, S. A.; Leblond, V.; Maloney, D. G.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • MRD response-driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Meeting Abstract

    Korde, N.; Mailankody, S.; Smith, E. L.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hultcrantz, M.; Chung, D. J.; Shah, G. L.; Koehne, G.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Final analysis of the phase I/II study of CC-486 (oral azacitidine) maintenance therapy after allogeneic stem cell transplantation (allo-SCT) in patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS)
    Meeting Abstract

    de Lima, M.; Oran, B.; Champlin, R. E.; Papadopoulos, E. B.; Giralt, S. A.; Scott, B. L.; William, B. M.; Hetzer, J.; Hubbell, B.; Skikne, B. S.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Characterizing ionizing radiation exposure after T-cell depleted allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Cho, C.; Maloy, M.; Devlin, S. M.; Aras, O.; Castro-Malaspina, H. R.; Dauer, L. T.; Jakubowski, A. A.; O'Reilly, R. J.; Papadopoulos, E. B.; Perales, M. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Efficacy of donor lymphocyte infusion in CD34+ selected allogeneic hematopoietic stem cell transplant for myeloid and lymphoid malignancies: A single center experience
    Meeting Abstract

    Bryant, A.; Devlin, S. M.; Castro-Malaspina, H. R.; Jakubowski, A. A.; Maloy, M.; Papadopoulos, E. B.; Giralt, S. A.; Perales, M. A.
    Blood (2017)

    Fulltext@MSK | Save
  • Quantitative analysis of T1-weighted MRI images as a surrogate for fat content does not correlate with response or survival
    Meeting Abstract

    Amer, A.; Gunjan, S.; Benjamin, D.; Sean, D.; Molly, M.; Yousef, M.; David, C.; Guenther, K.; Nikoletta, L.; Heather, L.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Final efficacy and safety results from a defibrotide expanded-access program for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome
    Meeting Abstract

    Richardson, P.; Smith, A.; Triplett, B.; Kernan, N.; Grupp, S.; Antin, J.; Lehmann, L.; Giralt, S.; Arai, S.; Ryan, R.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: A landmark analysis
    Journal Article

    Cho, C.; Hsu, M.; Barba, P.; Maloy, M. A.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • FDA approval of tisagenlecleucel: Promise and complexities of a $475 000 cancer drug
    Journal Article

    Bach, P. B.; Giralt, S. A.; Saltz, L. B.
    JAMA - Journal of the American Medical Association (2017)

    Fulltext@MSK | Save
  • The impact of toxicities on first-year outcomes after ex vivo CD34(+)-selected allogeneic hematopoietic cell transplantation in adults with hematologic malignancies
    Journal Article

    Kosuri, S.; Herrera, D. A.; Scordo, M.; Shah, G. L.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Nieves, J.; Borrill, T.; Carlow, D. C.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save